220 related articles for article (PubMed ID: 20664492)
21. The Changes of Irisin and Inflammatory Cytokines in the Age-Related Macular Degeneration and Retinal Vein Occlusion.
Li X; Cao X; Zhao M; Bao Y
Front Endocrinol (Lausanne); 2022; 13():861757. PubMed ID: 35370941
[TBL] [Abstract][Full Text] [Related]
22. Aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion.
Kim JH; Shin JP; Kim IT; Park DH
Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):6-11. PubMed ID: 26746013
[TBL] [Abstract][Full Text] [Related]
23. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Shimada K; Hori S
Curr Eye Res; 2011 Mar; 36(3):256-63. PubMed ID: 21275514
[TBL] [Abstract][Full Text] [Related]
24. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor receptor-2 in macular oedema with retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S
Ophthalmic Res; 2012; 48(1):56-8. PubMed ID: 22415022
[TBL] [Abstract][Full Text] [Related]
26. Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion.
Park SP; Ahn JK; Mun GH
Retina; 2010 Feb; 30(2):281-6. PubMed ID: 19881397
[TBL] [Abstract][Full Text] [Related]
27. Intraocular cytokines in retinal vein occlusion and its relation to the efficiency of anti-vascular endothelial growth factor therapy.
Shchuko AG; Zlobin IV; Iureva TN; Ostanin AA; Chernykh ER; Mikhalevich IM
Indian J Ophthalmol; 2015 Dec; 63(12):905-11. PubMed ID: 26862095
[TBL] [Abstract][Full Text] [Related]
28. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion.
Jung SH; Kim KA; Sohn SW; Yang SJ
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091
[TBL] [Abstract][Full Text] [Related]
29. Influence of vitreous factors after vitrectomy for macular edema in patients with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Shimada K
Int Ophthalmol; 2011 Oct; 31(5):393-402. PubMed ID: 22105941
[TBL] [Abstract][Full Text] [Related]
30. LYSOPHOSPHATIDIC ACIDS AND AUTOTAXIN IN RETINAL VEIN OCCLUSION.
Dacheva I; Ullmer C; Ceglowska K; Nogoceke E; Hartmann G; Müller S; Rejdak R; Nowomiejska K; Reich M; Nobl M; Tandogan T; Kretz FT; Auffarth GU; Koss MJ
Retina; 2016 Dec; 36(12):2311-2318. PubMed ID: 27648638
[TBL] [Abstract][Full Text] [Related]
31. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
[TBL] [Abstract][Full Text] [Related]
32. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
[TBL] [Abstract][Full Text] [Related]
33. Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor.
Yamasaki M; Noma H; Funatsu H; Minamoto A; Mimura T; Shimada K; Yamashita H; Kiuchi Y
Int Ophthalmol; 2009 Jun; 29(3):161-7. PubMed ID: 18797821
[TBL] [Abstract][Full Text] [Related]
34. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
[TBL] [Abstract][Full Text] [Related]
35. Aqueous soluble vascular endothelial growth factor receptor-2 in macular edema with branch retinal vein occlusion.
Noma H; Mimura T
Curr Eye Res; 2013 Dec; 38(12):1288-90. PubMed ID: 23972086
[TBL] [Abstract][Full Text] [Related]
36. Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema.
Noma H; Mimura T; Yasuda K; Shimura M
Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3878-85. PubMed ID: 24894397
[TBL] [Abstract][Full Text] [Related]
37. Aqueous levels of VEGF correlate with retinal non-perfusion areas in patients with diabetic macular edema and macular edema secondary to central retinal vein occlusion.
Machalinska A; Mozolewska-Piotrowska K; Czepita M; Spoz W; Dzieciolowska M; Kubasik-Kladna K; Szmatloch K; Lubinski W; Safranow K; Pius-Sadowska E
Klin Oczna; 2016 Sep; 117(4):225-229. PubMed ID: 29727107
[TBL] [Abstract][Full Text] [Related]
38. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of ranibizumab after intravitreal administration in patients with retinal vein occlusion or diabetic macular edema.
Zhang Y; Yao Z; Kaila N; Kuebler P; Visich J; Maia M; Tuomi L; Ehrlich JS; Rubio RG; Campochiaro PA
Ophthalmology; 2014 Nov; 121(11):2237-46. PubMed ID: 25001159
[TBL] [Abstract][Full Text] [Related]
40. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; King J; Antoszyk AN; Peters MA; Tolentino M;
JAMA Ophthalmol; 2017 Jun; 135(6):639-649. PubMed ID: 28492860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
